http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 11 Jun 2026 16:06:01 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Penumbra+receives+FDA+clearance+for+stroke+thrombectomy+device/26635609.html <p>Penumbra Inc. (NYSE: PEN) announced it received U.S. Food and Drug Administration clearance for THUNDERBOLT, a computer assisted vacuum thrombectomy device designed to treat acute ischemic stroke.</p><p>The device represents the first computer assisted vacuum thrombectomy platform to deliver modulated aspiration for acute ischemic stroke treatment. THUNDERBOLT uses technology designed to detect, fatigue, and remove blood clots at the site of arterial blockages.</p><p>The system will be packaged with one of Penumbra's catheters including RED 62, RED 68, RED 72 SILVER LABEL or RED 72 SILVER LABEL with SENDit technology. The device is powered by the company's ENGINE platform.</p><p>According to the press http://www.streetinsider.com/Corporate+News/Penumbra+receives+FDA+clearance+for+stroke+thrombectomy+device/26635609.html Thu, 11 Jun 2026 16:06:01 -0400 PEN http://www.streetinsider.com/FDA/Penumbra+receives+FDA+clearance+for+stroke+thrombectomy+device/26635609.html <p>Penumbra Inc. (NYSE: PEN) announced it received U.S. Food and Drug Administration clearance for THUNDERBOLT, a computer assisted vacuum thrombectomy device designed to treat acute ischemic stroke.</p><p>The device represents the first computer assisted vacuum thrombectomy platform to deliver modulated aspiration for acute ischemic stroke treatment. THUNDERBOLT uses technology designed to detect, fatigue, and remove blood clots at the site of arterial blockages.</p><p>The system will be packaged with one of Penumbra's catheters including RED 62, RED 68, RED 72 SILVER LABEL or RED 72 SILVER LABEL with SENDit technology. The device is powered by the company's ENGINE platform.</p><p>According to the press http://www.streetinsider.com/FDA/Penumbra+receives+FDA+clearance+for+stroke+thrombectomy+device/26635609.html Thu, 11 Jun 2026 16:06:01 -0400 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html <div class="xn-content"> <p class="prntac"><i>THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.alaeda" idsrc="xmltag.org" >ALAMEDA, Calif.</location></span>, <span class="legendSpanClass"><chron>June 11, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=2487780600&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc" target="_blank" rel="nofollow"><span value="NYSE:PEN" idsrc="xmltag.org" >Penumbra, Inc</span></a>. (NYSE: PEN), the world's leading thrombectomy company, announced it has received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> (FDA) clearance for <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4709933-1&amp;h=3233720426&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2Fproducts%2Fthunderbolt&amp;a=THUNDERBOLT%E2%84%A2" target="_blank" rel="nofollow">THUNDERBOLT™</a>, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Penumbra%27s+THUNDERBOLT+Receives+FDA+Clearance+-+Bringing+Computer+Assisted+Vacuum+Thrombectomy+Technology+to+Stroke/26635580.html Thu, 11 Jun 2026 16:05:00 -0400 A.06822034 A.07275906 A.60012012 O.01770044 O.20026344 O.20847516 O.31842592 PEN http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Penumbra+Inc+++++++++++++++++++++++++/26575875.html si-local-file:///var/storage/secattach/20260529/26575875.html http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Penumbra+Inc+++++++++++++++++++++++++/26575875.html Fri, 29 May 2026 16:36:00 -0400 O.01770044 PEN http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Penumbra+Inc+++++++++++++++++++++++++/26575875.html si-local-file:///var/storage/secattach/20260529/26575875.html http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Penumbra+Inc+++++++++++++++++++++++++/26575875.html Fri, 29 May 2026 16:36:00 -0400 O.01770044 PEN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Penumbra+Inc++++++++++++++For%3A+May+19++Filed+by%3A+Elsesser+Adam/26537405.html si-local-file:///var/storage/secattach/20260521/26537405.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Penumbra+Inc++++++++++++++For%3A+May+19++Filed+by%3A+Elsesser+Adam/26537405.html Thu, 21 May 2026 19:36:00 -0400 O.01770044 PEN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Penumbra+Inc++++++++++++++For%3A+May+19++Filed+by%3A+Elsesser+Adam/26537405.html si-local-file:///var/storage/secattach/20260521/26537405.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Penumbra+Inc++++++++++++++For%3A+May+19++Filed+by%3A+Elsesser+Adam/26537405.html Thu, 21 May 2026 19:36:00 -0400 O.01770044 PEN http://www.streetinsider.com/SEC+Filings/Form++425++++++++Penumbra+Inc+++++++++++++++++++++++++++Filed+by%3A+Penumbra+Inc/26449783.html si-local-file:///var/storage/secattach/20260507/26449783.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++Penumbra+Inc+++++++++++++++++++++++++++Filed+by%3A+Penumbra+Inc/26449783.html Thu, 07 May 2026 09:02:00 -0400 O.01770044 PEN http://www.streetinsider.com/SEC+Filings/Form++425++++++++Penumbra+Inc+++++++++++++++++++++++++++Filed+by%3A+Penumbra+Inc/26449783.html si-local-file:///var/storage/secattach/20260507/26449783.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++Penumbra+Inc+++++++++++++++++++++++++++Filed+by%3A+Penumbra+Inc/26449783.html Thu, 07 May 2026 09:02:00 -0400 O.01770044 PEN http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Penumbra+Inc++++++++++++++For%3A+May+06/26449717.html si-local-file:///var/storage/secattach/20260507/26449717.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Penumbra+Inc++++++++++++++For%3A+May+06/26449717.html Thu, 07 May 2026 09:01:00 -0400 O.01770044 PEN